OptimizeRx
OPRX
86 hedge funds and large institutions have $310M invested in OptimizeRx in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 5 closing their positions.
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
251% more call options, than puts
Call options by funds: $8.51M | Put options by funds: $2.42M
58% more capital invested
Capital invested by funds: $197M → $310M (+$114M)
33% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 24
26% more funds holding
Funds holding: 68 → 86 (+18)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
2.4% more ownership
Funds ownership: 63.6% → 66% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.49M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$5.39M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$2.34M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$2.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIPM
G2 Investment Partners Management
New York
|
-$5.62M |
| 2 |
AIC
AWM Investment Company
New York
|
-$5.1M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.79M |
| 4 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$1.36M |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$1.22M |
OPRX Hedge Fund Activity: Q4 2020 in Review
86 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2020, worth a combined $310M — up 58% from $197M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new OPRX positions and 5 closed out — a net gain of 18 holders — while 32 added to existing stakes and 24 trimmed.
The largest buyer was Next Century Growth Investors, opening a new position worth an estimated $5.49M. The largest seller was G2 Investment Partners Management, cutting an estimated $5.62M.
- 86 institutional investors held OptimizeRx (OPRX) as of Q4 2020, up from 68 in Q3 2020.
- Funds reported $310M of OptimizeRx stock for Q4 2020, up 58% quarter-over-quarter.
- 23 funds opened new OptimizeRx positions in Q4 2020 and 5 closed out, a net change of +18 holders.
- The largest OptimizeRx buyer in Q4 2020 was Next Century Growth Investors, an estimated $5.49M added.
- The largest OptimizeRx seller in Q4 2020 was G2 Investment Partners Management, an estimated $5.62M sold.
Based on aggregated 13F filings for Q4 2020.